Financhill
Back

Biohaven Pharmaceutical Holding 10K Form

Buy
75

BHVN
Biohaven Pharmaceutical Holding

Last Price:
151.51
Seasonality Move:
7.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive BHVN News And Ratings

See the #1 stock for the next 7 days that we like better than BHVN

BHVN Financial Statistics

Sales & Book Value

Annual Sales: $462.51M
Cash Flow: $-190.92M
Price / Cash Flow: 0
Annual Sales: $-11.26
Price / Book: 0

Profitability

EPS (TTM): -14.82000
Net Income (TTM): $-928.79M
Gross Margin: $370.85M
Return on Equity: 0%
Return on Assets: -79.9%

Key Biohaven Pharmaceutical Holding Financial Ratios

  • The Gross Profit Margin over the past 4 years for BHVN is 80.18%.
  • The Selling, General & Administrative Expenses for BHVN have been equal to 154.28% of Gross Profit Margin.
  • The Research & Development expenses have been 78.13% of Revenue.
  • The Interest Expense is -15.88% of Operating Income.
  • The Net Earning history of BHVN is -183.04% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 0 years.

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Biotechnology
Sector: Healthcare
Current Symbol: BHVN
CUSIP: G11196
Website: biohavenpharma.com

Debt

Debt-to-Equity Ratio: -0.96
Current Ratio: 1.75
Quick Ratio: 1.35

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BHVN Technical Analysis vs Fundamental Analysis

Buy
75
Biohaven Pharmaceutical Holding (BHVN) is a Buy

Is Biohaven Pharmaceutical Holding a Buy or a Sell?